Written in February 2015, an edited version of this blog was published in the Spring Issue of Baseline magazine. In the UK, 6,000 people were newly diagnosed with HIV in 2013, down from the 7,890 peak in 2005. This decrease masks an evolving epidemic with
On October 16 the PROUD Study Team announced that all participants enrolled in this pilot trial of daily Pre-Exposure Prophylaxis (PrEP) in the UK will be offered immediate PrEP. This was a challenging decision for the ANRS-led IPERGAY study which is investigating the efficacy of
In a surprising move, the World Health Organisation has come out in support of Pre-Exposure Prophylaxis (PrEP), recommending Men who have Sex with Men (MSM) to consider its use for HIV prevention alongside the use of condoms. It will be a huge challenge for countries
The New York Times started a debate on Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection by asking five prominent researchers and HIV advocates to discuss whether promoting the use of antiviral drugs was a good public health strategy, or if it will encourage more
The participation and contribution of healthy human volunteers in clinical research is key to the successful development of new approaches to HIV prevention. But what is a “healthy volunteer”? The successful development of a HIV vaccine or of a New HIV Prevention Technology (NPT, such